Table 3.
Frequencies of studied Genes among studied patients (n = 105).
| Gene | Call rate (%) | Genotype/Allele | No. (%) | MAF, Global (1000genomes/our cohort | H.W.E |
|---|---|---|---|---|---|
| P value | |||||
| RS 2740574 | 100 | CC | 4 (3.8) | – | 0.202 |
| CT | 18 (17.1) | ||||
| TT | 83 (79.0) | ||||
| C | 26 (12.38) | C = 0.2308/0.1238 | |||
| T | 184 (87.6) | T = 0.7692/0.8762 | |||
| RS 11572080 | 95.8 | CC | 73 (69.5) | 0.352 | |
| CT | 32 (30.5) | ||||
| C | 178 (84.7) | C = 0.9543 /0.8476 | |||
| T | 32 (15.2) | T = 0.0457/0.1524 |
MAF minor allele frequency; risk allele is presented in bold; H.W.E. Hardy–Weinberg equilibrium.